Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer

Completed · Phase 2

Conditions studied: Prostate Cancer, Thromboembolism

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Anticoagulant drugs such as warfarin may reduce the risk of blood clots. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus warfarin in treating patients who have prostate cancer.

Key facts

Study ID

NCT00014352

Run by

Memorial Sloan Kettering Cancer Center

Starts

2000-09-01

Last updated by the study team

2013-01-16

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.